Drug class
Combination antibacterial: aminopenicillin (amoxicillin) plus beta-lactamase inhibitor (clavulanic acid)
Mechanism of action
Amoxicillin binds penicillin-binding proteins and inhibits bacterial peptidoglycan cell-wall synthesis, causing cell-wall weakening and lysis. Clavulanic acid inactivates certain beta-lactamases and protects amoxicillin from enzymatic degradation; it has no clinically useful antibacterial action alone.
General use cases
- Treatment of infections caused by susceptible organisms, including selected respiratory, ear/nose/throat, urinary, skin/soft-tissue, dental and bone/joint infections; the exact indications vary by strength, formulation and local product information
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
